Sekeres MA - Search Results

1

Results of a Phase 1/2a dose-escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromes.

Garcia-Manero G, Pemmaraju N, Alvarado Y, Naqvi K, Ravandi F, Jabbour E, De Lumpa R, Kantarjian H, Advani A, Mukherjee S, Gerds A, Carraway HE, Nazha A, Iwamura H, Murase M, Bavisotto L, Kurman M, Maier G, Johansen M, Sekeres MA. Garcia-Manero G, et al. Among authors: sekeres ma. Leuk Lymphoma. 2020 Aug;61(8):1943-1953. doi: 10.1080/10428194.2020.1747065. Epub 2020 Apr 7. Leuk Lymphoma. 2020. PMID: 32264726 Clinical Trial.

2

Acute myeloid leukemia.

Stone RM, O'Donnell MR, Sekeres MA. Stone RM, et al. Among authors: sekeres ma. Hematology Am Soc Hematol Educ Program. 2004:98-117. doi: 10.1182/asheducation-2004.1.98. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561679 Review.

3

The role of post-remission chemotherapy for older patients with acute myelogenous leukemia.

Abou-Jawde RM, Sobecks R, Pohlman B, Rybicki L, Advani A, Sekeres M, Kalaycio M. Abou-Jawde RM, et al. Leuk Lymphoma. 2006 Apr;47(4):689-95. doi: 10.1080/10428190500353554. Leuk Lymphoma. 2006. PMID: 16690528

4

Immunomodulation in myelodysplastic syndromes.

Sekeres MA, List A. Sekeres MA, et al. Best Pract Res Clin Haematol. 2006;19(4):757-67. doi: 10.1016/j.beha.2006.06.001. Best Pract Res Clin Haematol. 2006. PMID: 16997181 Review.

5

The myelodysplastic syndromes.

Sekeres MA. Sekeres MA. Expert Opin Biol Ther. 2007 Mar;7(3):369-77. doi: 10.1517/14712598.7.3.369. Expert Opin Biol Ther. 2007. PMID: 17309328 Review.

6

The incidence and impact of thrombocytopenia in myelodysplastic syndromes.

Kantarjian H, Giles F, List A, Lyons R, Sekeres MA, Pierce S, Deuson R, Leveque J. Kantarjian H, et al. Among authors: sekeres ma. Cancer. 2007 May 1;109(9):1705-14. doi: 10.1002/cncr.22602. Cancer. 2007. PMID: 17366593 Free article. Review.

7

Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes.

Golshayan AR, Jin T, Maciejewski J, Fu AZ, Bershadsky B, Kattan MW, Kalaycio ME, Sekeres MA. Golshayan AR, et al. Among authors: sekeres ma. Br J Haematol. 2007 Apr;137(2):125-32. doi: 10.1111/j.1365-2141.2007.06546.x. Br J Haematol. 2007. PMID: 17391492 Free article. Review.

8

White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia.

Han HS, Rybicki LA, Thiel K, Kalaycio ME, Sobecks R, Advani A, Brown S, Sekeres MA. Han HS, et al. Among authors: sekeres ma. Leuk Lymphoma. 2007 Aug;48(8):1561-8. doi: 10.1080/10428190701474373. Leuk Lymphoma. 2007. PMID: 17701588

9

Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.

Baz R, Rodriguez C, Fu AZ, Jawde RA, Kalaycio M, Advani A, Sobecks R, Sekeres MA. Baz R, et al. Among authors: sekeres ma. Cancer. 2007 Oct 15;110(8):1752-9. doi: 10.1002/cncr.22976. Cancer. 2007. PMID: 17724726 Free article.

10

Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia.

Rodriguez CP, Baz R, Jawde RA, Rybicki LA, Kalaycio ME, Advani A, Sobecks R, Sekeres MA. Rodriguez CP, et al. Among authors: sekeres ma. Leuk Res. 2008 Mar;32(3):413-20. doi: 10.1016/j.leukres.2007.07.015. Epub 2007 Aug 28. Leuk Res. 2008. PMID: 17727945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters